Genome Diagnostics, cancer-test maker, aims for $1.6M

David P. Hamilton | November 28th, 2007

See our story on this Pasadena, Calif., developer of cancer tests supposedly based on whole-genome sequencing in today’s daily briefing at VentureBeat Life Sciences.

Sphere It Digg this story!
Trackback URL

One Comment

  1. December 3rd, 2007
    2:31 pm

    Elai Davicioni said:

    Hi David,
    We are developing whole-transcriptome expression profiles of cancer patients for individualized treatment diagnostics/prognostics. Please do not hesistate to contact me for further (accurate) info.
    Best,
    Elai
    Elai Davicioni, Ph.D.
    President & CEO
    Genome Diagnostics, Inc.
    80 S. Lake Avenue, Suite 680
    Pasadena, CA, 91101-2615, USA
    Office: 626-529-0516
    Mobile: 626-710-2695
    eFax: 1-866-505-5161
    eMail: elai@genomedx.com
    http://www.genomedx.com

Add a Comment